Production (Stage)
The Oncology Institute, Inc.
TOI
$3.02
$0.031.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.64% | -40.05% | -45.77% | 18.32% | 18.87% |
| Total Receivables | -16.00% | 13.45% | 12.17% | 15.94% | 27.47% |
| Inventory | 6.53% | -26.60% | -16.99% | -6.95% | 12.68% |
| Prepaid Expenses | 9.17% | -0.49% | -3.17% | -28.66% | -32.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.34% | -21.66% | -23.75% | 11.66% | 18.69% |
|
|
|||||
| Total Current Assets | -24.34% | -21.66% | -23.75% | 11.66% | 18.69% |
| Net Property, Plant & Equipment | -8.03% | -5.95% | 0.09% | -1.48% | 11.26% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 58.87% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 58.87% |
| Total Other Intangibles | -18.07% | -17.28% | -16.04% | -15.44% | -0.56% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.05% | 4.99% | 5.00% | 4.49% | 7.78% |
| Total Assets | -19.82% | -17.46% | -17.94% | -21.90% | -12.83% |
|
|
|||||
| Total Accounts Payable | 39.38% | 68.58% | 84.29% | 20.02% | 75.92% |
| Total Accrued Expenses | 3.92% | 21.27% | 35.31% | 3.04% | 17.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.55% | 7.42% | 10.97% | 8.64% | 12.59% |
| Total Finance Division Other Current Liabilities | 46.40% | 145.15% | 3.80% | -21.07% | 85.21% |
| Total Other Current Liabilities | 46.40% | 145.15% | 3.80% | -21.07% | 85.21% |
| Total Current Liabilities | 30.09% | 50.09% | 44.36% | 4.76% | 52.13% |
|
|
|||||
| Total Current Liabilities | 30.09% | 50.09% | 44.36% | 4.76% | 52.13% |
| Long-Term Debt | -16.40% | 7.26% | 7.37% | 7.48% | 7.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.91% | -12.08% | -5.31% | -8.04% | 12.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.19% | -87.97% | -75.48% | -42.95% | 146.43% |
| Total Liabilities | -2.64% | 11.11% | 11.74% | 3.55% | 19.83% |
|
|
|||||
| Common Stock & APIC | 13.50% | 5.50% | 6.92% | 8.26% | 8.81% |
| Retained Earnings | -38.76% | -44.24% | -55.13% | -65.05% | -78.38% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -13.98% | -- |
| Total Common Equity | -87.73% | -93.71% | -78.45% | -65.53% | -58.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -87.73% | -93.71% | -78.45% | -65.53% | -58.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -87.73% | -93.71% | -78.45% | -65.53% | -58.04% |
|
|
|||||